Detalles de la búsqueda
1.
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study.
Ann Rheum Dis;
80(1): 96-102, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32719038
2.
Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.
Rheumatology (Oxford);
59(2): 292-302, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31312844
3.
Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng et al.
Ann Rheum Dis;
81(11): e225, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177102
4.
Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters.
J Clin Pharmacol;
61(5): 714-724, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33314148
5.
Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry.
Arthritis Care Res (Hoboken);
73(4): 471-480, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002337
6.
Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite.
Mol Microbiol;
71(3): 583-93, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19040639
7.
Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open-Label Extension of a Randomized Clinical Trial.
ACR Open Rheumatol;
2(11): 672-680, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33164349
8.
Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies.
Arthritis Res Ther;
22(1): 139, 2020 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32522251
9.
Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid Arthritis.
CPT Pharmacometrics Syst Pharmacol;
9(7): 405-416, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32453485
10.
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension.
RMD Open;
5(2): e001017, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31673415
11.
Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment.
RMD Open;
5(2): e000887, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31452928
12.
Peptide methionine sulfoxide reductase: structure, mechanism of action, and biological function.
Arch Biochem Biophys;
397(2): 172-8, 2002 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11795868
Resultados
1 -
12
de 12
1
Próxima >
>>